Elevations of DNA Topoisomerase I in Invasive Carcinoma of the Breast
- 1 May 2001
- journal article
- research article
- Published by Hindawi Limited in The Breast Journal
- Vol. 7 (3) , 176-180
- https://doi.org/10.1046/j.1524-4741.2001.007003176.x
Abstract
DNA topoisomerase I (topo I) is the molecular target of the camptothecin group of anticancer drugs. Laboratory experiments indicate that breast cancer cell lines are sensitive to these agen...Keywords
This publication has 10 references indexed in Scilit:
- Clinical applications of the camptothecinsBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1998
- Phase II trial of paclitaxel and topotecan with granulocyte colony-stimulating factor support in stage IV breast cancer.Journal of Clinical Oncology, 1998
- Increased Camptothecin Toxicity Induced in Mammalian Cells Expressing Saccharomyces cerevisiae DNA Topoisomerase IPublished by Elsevier ,1998
- A Model for the Mechanism of Human Topoisomerase IScience, 1998
- Human DNA topoisomerase II-alpha: A new marker of cell proliferation in invasive breast cancerHuman Pathology, 1997
- Immunohistochemical detection of DNA topoisomerase I in formalin fixed, paraffin wax embedded normal tissues and in ovarian carcinomas.Molecular Pathology, 1997
- Camptothecin exhibits selective cytotoxicity towards human breast carcinoma as compared to normal bovine endothelial cells in vitroAnti-Cancer Drugs, 1996
- Variation in topoisomerase I gene copy number as a mechanism for intrinsic drug sensitivityBritish Journal of Cancer, 1996
- Vinorelbine and the topoisomerase 1 inhibitors: Current and potential roles in breast cancer chemotherapyBreast Cancer Research and Treatment, 1995
- Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle.Proceedings of the National Academy of Sciences, 1988